BALYASNY ASSET MANAGEMENT L.P. - KRYSTAL BIOTECH INC ownership

KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 190 filers reported holding KRYSTAL BIOTECH INC in Q2 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of KRYSTAL BIOTECH INC
ValueSharesWeighting
Q2 2024$13,738,108
-37.8%
74,810
-39.8%
0.02%
-38.5%
Q1 2024$22,099,440
-30.6%
124,203
-51.6%
0.04%
-35.0%
Q4 2023$31,834,292
+740.7%
256,604
+686.1%
0.06%
+650.0%
Q3 2023$3,786,472
-11.9%
32,642
-10.8%
0.01%
-11.1%
Q2 2023$4,295,666
+30.4%
36,590
-11.0%
0.01%
+12.5%
Q1 2023$3,293,268
+396.3%
41,135
+391.1%
0.01%
+300.0%
Q4 2022$663,5478,3760.00%
Other shareholders
KRYSTAL BIOTECH INC shareholders Q2 2023
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 895,000$38,530,0003.46%
S Squared Technology, LLC 80,215$3,453,0002.57%
First Light Asset Management, LLC 464,663$20,004,0002.05%
Redmile Group, LLC 1,501,945$64,659,0001.19%
Nicholas Investment Partners, LP 222,422$9,575,0001.04%
SPHERA FUNDS MANAGEMENT LTD. 184,573$7,946,0000.78%
HighMark Wealth Management LLC 18,894$813,0000.73%
Hood River Capital Management LLC 257,203$11,073,0000.48%
GARNET EQUITY CAPITAL HOLDINGS, INC. 40,000$1,722,0000.35%
Artal Group S.A. 237,500$10,224,0000.25%
View complete list of KRYSTAL BIOTECH INC shareholders